| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-20457G |
| M.Wt: | 331.37 |
| Formula: | C20H17N3O2 |
| Purity: | >98 % |
| Solubility: |
TL8-506 (GMP) is TL8-506 (HY-20457) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. TL8-506 is a specific TLR8 agonist with an EC50 of 30 nM. TL8-506 has immunomodulatory effects and can be used in the study of tuberculosis and cancer immunotherapy[1][2].
In Vitro:TL8-506 (1 μM; 18 h) can activate dendritic cells in blood and tumors, induce the secretion of pro-inflammatory cytokines and chemokines, and promote the activation and recruitment of T cells (TL8-506 synergized with IFN-γ or Poly(I:C))[1].
TL8-506 can specifically activate TLR8 in vitro in TLR8 transgenic mouse bone marrow cells[2].
In Vivo:TL8-506 (intramuscular injection; twice; four weeks apart) can enhance the resistance to mycobacterium tuberculosis infection in TLR8 transgenic mice(TL8-506 and ESAT-6, aluminum hydroxide vaccine)[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.